CHICMAX

2145
22.7200.98% ( +0.220 )
Delay Closed: Nov 16, 16:08:11

Overview

CHICMAX (2145)

Shanghai Chicmax Cosmetic Co., Ltd., a multi-brand cosmetics company, engages in the research, development, manufacture, and sale of cosmetics in Mainland China...

Open
22.500
High
22.960
Low
22.500
Prev. Close
22.500
Volume
605.40K
Turnover
13.73M
Avg Price
22.671
Bid/Ask Ratio
-14.29%
Amplitude
2.04%
52wk High
89.143
Volume Ratio
0.44
Turnover Ratio
0.30%
52wk Low
20.000
HK Mkt Cap
4.51B
Market CapHKD
8.87B
P/ETTM
11.22
P/EDynamic
35.60
P/EStatic
--
EPSTTM
2.03
EPSDynamic
0.638
EPSStatic
--
BVPS
7.55
P/B
3.01
HK Shares
198.54M
Dividend YieldTTM
3.85%
DividendTTM
0.874
Shares
390.29M
Min lot size
100
Currency
HKD

CHICMAX Analyst Rating

View more

Forecast & Rating

Nov 10, 2026
Price forecast
HK$32.1741.61%
Forecast & RatingBuy
10analysts
  • Strong buy50.00%
  • Buy10.00%
  • Hold40.00%
  • Sell0.00%
  • Strong sell0.00%

Daily Events

  1. Nov, 16

    After plunging 67% year-to-date from an opening price of 69.4 HKD, Shanghai Chicmax trades near 22.72 HKD today, consolidating within a tight intraday range between 22.50 and 22.96 HKD levels, having recovered 13.6% from August's 52-week low of 20 HKD. The company faces severe profitability deterioration—recent quarterly results show earnings per share crashing roughly 78% year-over-year, with operating income collapsing 87% year-over-year, reflecting intensifying operational pressures and market headwinds; revenue also declined 3.6% year-over-year, underscoring persistent demand weakness in the cosmetics sector. Despite this pronounced earnings collapse, management has been actively implementing share repurchase programs, and Huatai Securities maintained a 'Buy' rating in October, both actions providing meaningful price support at these depressed valuation levels. The market currently prices the stock at 11.2x PE, an assessment that reflects embedded expectations for eventual business recovery; however, the magnitude of recent earnings deterioration combined with the company's thin 2.88% net profit margin suggests that any meaningful rebound in profitability will require substantial time to materialize.

  2. Nov, 13

    Shanghai Chicmax shares fell 1.66% to HKD 22.50 today, a modest decline that underscores the severity of the year-to-date selloff of 67.58% from 69.4, leaving the stock 75% below its 52-week peak of 90. The core challenge stems from sharply deteriorating profitability: Q2 earnings per share collapsed 78.25% year-over-year to 0.1569 HKD, while operating profit plunged 87.41%, signaling severe margin compression despite revenue declining only 3.61% year-over-year, suggesting underlying demand remains relatively stable but pricing power has eroded significantly. Valuation metrics appear compressed at P/E 11.11x and P/B 2.98x, with the stock trading below its 20-day moving average of 22.841. Management's sustained share buyback program and recent buy rating from Huatai Securities reflect confidence in stabilization, yet the magnitude of earnings deterioration demands visible operational improvement before conviction can be established.

  3. Nov, 12

    Shanghai Chicmax declined roughly 2% to HKD22.88 today, pressured by sharply deteriorating recent earnings. Latest quarterly results show Q2 and Q1 earnings per share plummeted 78% year-over-year, while operating profit tumbled 87% in the comparable period, reflecting severe headwinds in core profitability. The stock has fallen from its 52-week high of HKD90 reached last November to current levels, representing a cumulative drawdown exceeding 74%, with year-to-date losses reaching 67%. Against this backdrop, the company's consistent share buyback activity and buy-rating from Huatai Securities suggest management confidence, with a current PE of merely 11.3x indicating compressed valuation. However, net profit margins remain stuck at 2.88% in recent quarters and ROE hovers around 8%, suggesting near-term earnings recovery remains uncertain.

  4. Nov, 11

    Shanghai Chicmax closed down 0.68% at HK$23.38, continuing its dramatic year-to-date decline of 66.31%. After advancing to a session high of HK$23.92 in morning trading, the stock retreated in afternoon sessions as weakness persisted. The stock is now trading 74% below its 52-week high of HK$90, indicating sustained pressure on valuations. Q2 earnings revealed stark operational challenges: EPS collapsed 78.25% year-over-year to HK$0.1569, while revenue edged down 3.61% to HK$2.17 billion, and net margins compressed to just 2.88%. The valuation appears compressed at 11.5x forward earnings, though that metric masks deteriorating profitability, with ROE at 8.45% suggesting strained capital efficiency. Management has accelerated a share buyback program and Huatai Securities initiated 'Buy' coverage, but investor interest remains muted, reflected in subdued trading activity with turnover at just 0.24% of market capitalization.

  5. Nov, 10

    Stock price rose 1.1% to HK$23.76 today, but intraday volatility remained notable with a low of HK$22.82 in the morning session and recovery to HK$23.78 in the afternoon. Persistent earnings headwinds are the fundamental drag: Q2 operating profit fell 87% year-on-year to HK$33.6M, net income dropped 78% to HK$62.5M, and EPS stood at just HK$0.16. The stock has slumped 66% year-to-date and sits 74% below the 52-week high of HK$90 reached in November 2025. However, the company has continued announcing share buyback programs, and Huatai Securities has maintained a buy rating, offering some technical support that partly explains today's afternoon recovery; yet the company's sharply deteriorated profitability remains the main headwind preventing any sustained upside.

News

Bullish vs. Bearish — Last 3 Months

1.3k followers · 0 opinions
▲Bullish50%
50%Bearish▼